Shanghai Haohai plans pre-marketing for $200m IPO
Shanghai Haohai Biological Technology is to start gauging investor appetite for its $200m IPO in Hong Kong next week, with books scheduled to open in mid-April.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts